Ribosomal protein L19 is a prognostic marker for human prostate cancer

Clinical Cancer Research

Volumn 12, Issue 7 I, 2006, Pages 2061-2065

  Bee, Alix ^a   Ke, Youqianq ^a   Forootan, Shiva ^a   Lin, Ke ^a   Beesley, Carol ^a   Forrest, Sharon E ^a   Foster, Christopher S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBOSOME PROTEIN; RIBOSOME PROTEIN L19; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN FOLDING;

BLOTTING, NORTHERN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RIBOSOMAL PROTEINS; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33646268817     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2445     Document Type: Article

References (20)

1. Crawford ED. Epidemiology of prostate cancer. Urology 2003;62:3-12.
2. Jing C, Beesley C, Foster CS, et al. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis-inducer. Cancer Res 2000;60:2390-8.
3. Adamson J, Morgan EA, Beesley C, et al. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 2003;22:2739-49.
4. Foster CS, Cornford P, Forsyth L, Djamgoz MBA, Ke Y. The cellular and molecular basis of prostate cancer. Br J Urol 1999;83:171-94.
5. Forootan SS, Foster CS, Aachi VR, Adamson J, Ke Y. Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 2005;118:2255-61.
6. Jing C, Abd-El Ghany M, Beesley C, et al. Tazarotene-induced Gene-1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst 2002;94:482-90.
7. Jing C, Rudland PS, Foster CS, Ke YQ. Microquantity differential display: a strategy for a systematic analysis of differential gene expression with a small quantity of starting RNA. Ann Biochem 2000;287:334-7.
8. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992;257:967-71.
9. Roesch A, Vogt T, Stolz W, et al. Discrimination between gene expression patterns in the invasive margin and the tumour core of malignant melanomas. Melanoma Res 2003;13:503-9.
10. Henry JL, Coggin DL, King CR. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Cancer Res 1993;53:1403-8.
11. Cornford P, Evans J, Dodson A. Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol 1999;154:137-44.
12. Deshmukh N, Foster CS. Grading prostate cancer. In: Foster CS, Bostwick DG, editors. Pathology of the prostate. Vol. 34. London: W.B. Saunders; 1998. p. 191-227.
13. Epstein JI, Allsbrook WC, Amin M, Egevad LL; The ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29:1228-42.
14. Deprez PH, Sempoux C, De Saeger C, et al. Expression of choecystokinin in the duodenum of patients with coeliac disease: respective role of atrophy and lymphocytic infiltration. Clin Sci (Lond) 2002;103:171-7.
15. Forootan SS, Ke Y, Jones AS, Helliwell TR. Basic fibroblast growth factor and angiogenesis in squamous carcinoma of the tongue. Oral Oncol 2000;36:437-43.
16. Kumabe T, Sohgma Y, Yamamoto T. Human cDNAs encoding elongation factor 1 gamma and the ribosomal protein L19. Nucleic Acids Res 1992;20:2598.
17. Maguire BA, Zimmermann RA. The ribosome in focus. Cell 2001;104:813-6.
18. Ramakrishnan V. Ribosome structure and the mechanism of translation. Cell 2002;108:557-72.
19. Fernandez-Pol JA. Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy. Anticancer Res 1996;1621:77-85.
20. Vaarala MH, Porvari KS, Kyllonen AP, et al. Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: confirmation of L7a and L37 over-expressed in prostate cancer tissue samples. Int J Cancer 1998;78:27-32.